Concentration-dependent binding of chlorpyrifos oxon to acetylcholinesterase.

The organophosphorus insecticides have been known for many years to cause cholinergic crisis in humans as a result of the inhibition of the critical enzyme acetylcholinesterase. The interactions of the activated, toxic insecticide metabolites (termed oxons) with acetylcholinesterase have been studied extensively for decades. However, more recent studies have suggested that the interactions of certain anticholinesterase organophosphates with acetylcholinesterase are more complex than previously thought since their inhibitory capacity has been noted to change as a function of inhibitor concentration. In the present report, chlorpyrifos oxon (O,O-diethyl O-(3,5,6-trichloro-2-pyridyl) phosphate) was incubated with human recombinant acetylcholinesterase in the presence of p-nitrophenyl acetate in order to better characterize kinetically the interactions of this oxon with enzyme. Determination of the dissociation constant, Kd, and the phophorylation rate constant, k2, for chlorpyrifos oxon with a range of oxon and p-nitrophenyl acetate concentrations revealed that Kd, but not k2, changed as a function of oxon concentration. Changes in p-nitrophenyl acetate concentrations did not alter these same kinetic parameters. The inhibitory capacity of chlorpyrifos oxon, as measured by ki (k2/Kd), was also affected as a result of the concentration-dependent alterations in binding affinity. These results suggest that the concentration-dependent interactions of chlorpyrifos oxon with acetylcholinesterase resulted from a different mechanism than the concentration-dependent interactions of acetylthiocholine. In the latter case, substrate bound to the peripheral anionic site of acetylcholinesterase has been shown to reduce enzyme activity by blocking the release of the product thiocholine from the active site gorge. With chlorpyrifos oxon, the rate of release of 3,5,6-trichloro-2-pyridinol is irrelevant since the active site is not available to interact with other oxon molecules after phosphorylation of Ser-203 has occurred.

[1]  L. Sultatos,et al.  Concentration-dependent interactions of the organophosphates chlorpyrifos oxon and methyl paraoxon with human recombinant acetylcholinesterase. , 2007, Toxicology and applied pharmacology.

[2]  P. Taylor,et al.  Substrate and Product Trafficking through the Active Center Gorge of Acetylcholinesterase Analyzed by Crystallography and Equilibrium Binding* , 2006, Journal of Biological Chemistry.

[3]  Jure Stojan,et al.  Structural insights into substrate traffic and inhibition in acetylcholinesterase , 2006, The EMBO journal.

[4]  L. Sultatos,et al.  Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  A. Shafferman,et al.  Stereoselectivity toward VX is determined by interactions with residues of the acyl pocket as well as of the peripheral anionic site of AChE. , 2004, Biochemistry.

[6]  L. Sultatos,et al.  Comparison of chlorpyrifos-oxon and paraoxon acetylcholinesterase inhibition dynamics: potential role of a peripheral binding site. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  N. Yamaotsu,et al.  Esterase-Like Activity of Serum Albumin: Characterization of Its Structural Chemistry Using p-Nitrophenyl Esters as Substrates , 2004, Pharmaceutical Research.

[8]  P. Fasanaro,et al.  Oxidative Stress Induces Protein Phosphatase 2A-dependent Dephosphorylation of the Pocket Proteins pRb, p107, and p130* , 2003, Journal of Biological Chemistry.

[9]  M. Davies,et al.  Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate. , 2003, Biochemistry.

[10]  P. Taylor,et al.  Reversibly Bound and Covalently Attached Ligands Induce Conformational Changes in the Omega Loop, Cys69–Cys96, of Mouse Acetylcholinesterase* , 2001, The Journal of Biological Chemistry.

[11]  N. Inestrosa,et al.  Thioflavin T Is a Fluorescent Probe of the Acetylcholinesterase Peripheral Site That Reveals Conformational Interactions between the Peripheral and Acylation Sites* , 2001, The Journal of Biological Chemistry.

[12]  H. Soreq,et al.  Acetylcholinesterase — new roles for an old actor , 2001, Nature Reviews Neuroscience.

[13]  N. Ariel,et al.  Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. , 2000, Acta crystallographica. Section D, Biological crystallography.

[14]  R. Rawbone,et al.  Rates of spontaneous reactivation and aging of acetyicholinesterase in human erythrocytes after inhibition by organophosphorus pesticides , 2000, Human & experimental toxicology.

[15]  P. Taylor,et al.  Probing the Active Center Gorge of Acetylcholinesterase by Fluorophores Linked to Substituted Cysteines* , 2000, The Journal of Biological Chemistry.

[16]  T. Rosenberry,et al.  Acetylthiocholine binds to asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway. , 2000, Biochemistry.

[17]  T. Rosenberry,et al.  Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect. , 1999, Biochemistry.

[18]  B Velan,et al.  Functional Characteristics of the Oxyanion Hole in Human Acetylcholinesterase* , 1998, The Journal of Biological Chemistry.

[19]  T. Rosenberry,et al.  Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands. , 1998, Biochemistry.

[20]  D. Fournier,et al.  Stabilization of RecombinantDrosophilaAcetylcholinesterase , 1998 .

[21]  D. Fournier,et al.  Stabilization of recombinant Drosophila acetylcholinesterase. , 1998, Protein expression and purification.

[22]  L G Sultatos,et al.  Common mechanism of toxicity: a case study of organophosphorus pesticides. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  B Velan,et al.  The Architecture of Human Acetylcholinesterase Active Center Probed by Interactions with Selected Organophosphate Inhibitors , 1996, The Journal of Biological Chemistry.

[24]  N. Ariel,et al.  Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite. , 1995, Biochemistry.

[25]  N. Ariel,et al.  Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding. , 1992, The Journal of biological chemistry.

[26]  J. R. Kemp,et al.  Molecular determinants of the species-selective inhibition of brain acetylcholinesterase. , 1990, Toxicology and applied pharmacology.

[27]  R. Duggleby,et al.  Analysis of kinetic data for irreversible enzyme inhibition. , 1989, The Biochemical journal.

[28]  C. Tsou,et al.  Determination of rate constants for the irreversible inhibition of acetylcholine esterase by continuously monitoring the substrate reaction in the presence of the inhibitor. , 1986, Biochimica et biophysica acta.

[29]  M. L. Bender,et al.  Acetylation of human serum albumin by p-nitrophenyl acetate. , 1975, Biochemistry.

[30]  R. O'brien Enzyme inhibitors as substrates: W. N. Aldridge and Elsa Reiner, Frontiers in Biology Series, Vol. 26, North Holland-American Elsevier, Amsterdam-New York, 1973. $22.50 , 1974 .

[31]  R. O'brien,et al.  Recording spectrophotometric method for determination of dissociation and phosphorylation constants for the inhibition of acetylcholinesterase by organophosphates in the presence of substrate. , 1973, Biochemistry.

[32]  E. Reiner,et al.  Enzyme inhibitors as substrates : interactions of esterases with esters of organophosphorus and carbamic acids , 1972 .

[33]  Fernández Jf Frontiers of biology , 1971 .